Category:
Other Preparations
CAS NO:
188627-80-7
Standard:
ChP,USP,
Eptifibatide is a platelet aggregation inhibitor primarily used in the treatment of acute coronary syndrome (ACS) and during percutaneous coronary intervention (PCI) to prevent cardiac ischemic complications. It works by blocking the platelet glycoprotein IIb/IIIa receptor, which is involved in the final pathway to platelet aggregation.
Eptifibatide Injection is a synthetic cyclic heptapeptide acting as a glycoprotein IIb/IIIa inhibitor. Manufactured via recombinant DNA technology, it features high-purity peptide synthesis with sterile filtration to ensure molecular stability and biological activity for acute cardiovascular intervention.